Daily Archives:September 28, 2017
Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its anticancer mechanism of action
Erufosine is an ether–lipid-derived synthetic compound belonging to the group of alkylphosphocholines (APCs). This chemotherapeutic agent exhibits pronounced anti-leukemic activity without affecting the normal hematopoiesis and exerts its influence by modulating signal transduction pathways in malignant tumor
14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology. Amsterdam, Netherlands. April 09-11, 2018
会议系列有限公司组织高度notable pharmaceutical conferences throughout the world. Currently we are bringing forth “14th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology” (NanoMed 2018) scheduled to be held during April 09-11, 2018 at
